SCHEMBL1974241

SCHEMBL1974241

CC(=O)Nc1ccc(-c2c3nc(c(-c4ccc(C)cc4)c4ccc([nH]4)c(-c4ccc(C(=O)O)cc4)c4nc(c(-c5ccc(C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 3/20 0.68
▸ CYCS P99999 4/20 0.67
▸ ABCG2 Q9UNQ0 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.46
▸ DHODH Q02127 1/20 0.45
▸ TERT O14746 1/20 0.44
▸ ENPP2 Q13822 1/20 0.43
▸ HPGD P15428 4/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910535 0.93 ABCG2 (0.55) TOP1CYCSABCG2TDP1DHODH
SCHEMBL1977052 0.89 TOP1 (0.86) TOP1CYCSABCG2TERTENPP2
SCHEMBL9976608 0.89 TOP1 (0.86) TOP1CYCSABCG2TERTENPP2
SCHEMBL8994447 0.88 TOP1 (0.60) TOP1CYCSABCG2TDP1TERT
SCHEMBL14077524 0.84 ABCG2 (0.54) TOP1CYCSABCG2TERTENPP2
SCHEMBL709532 0.83 TOP1 (1.00) TOP1CYCSABCG2TERTENPP2
SCHEMBL29354037 0.83 TOP1 (1.00) TOP1CYCSABCG2TERTENPP2
SCHEMBL7241022 0.82 TOP1 (0.58) TOP1CYCSABCG2TERTENPP2
SCHEMBL19268973 0.81 TOP1 (0.86) TOP1CYCSABCG2TERTENPP2
SCHEMBL12842181 0.81 CYCS (0.97) TOP1CYCSABCG2TERTENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809332-B1 COMPOSITIONS FOR MULTI-STEP DELIVERY OF HOT-SPOTS RADIATION TO CANCER CELLS ONCOLOGIC INC (US) 2011-12-14 — — EP disclosed
US-20110142756-A1 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer Rose, David S. (US) 2011-06-16 — — US disclosed
US-7807136-B2 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer Rose, David S. (US) 2010-10-05 — — US disclosed
US-20100062006-A9 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer MAYERS GEORGE L 2010-03-11 — — US disclosed
US-7615221-B2 Compositions and methods for treating cancer ONCOLOGIC, INC. (US) 2009-11-10 — — US disclosed
EP-1809332-A2 COMPOSITIONS FOR MULTI-STEP DELIVERY OF HOT-SPOTS RADIATION TO CANCER CELLS Oncologic, Inc. (US) 2007-07-25 — — EP disclosed
WO-2006010165-A2 COMPOSITIONS FOR MULTI-STEP DELIVERY OF HOT-SPOTS RADIATION TO CANCER CELLS ONCOLOGIC, INC. (US) 2006-01-26 — — WO disclosed
US-20060018908-A1 Compositions and methods for treating cancer ROSE, DAVID STUART 2006-01-26 — — US disclosed
US-20050058652-A1 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer ROSE, DAVID STUART 2005-03-17 — — US disclosed
Send feedback